OncoPharm cover image

Adjuvant Pembrolizumab (NSCLC), Elacestrant, & Pirtobrutinib

OncoPharm

00:00

Landscape of Targeted Adjuvant Therapy in NSCLC

John situates current adjuvant targeted and immunotherapy options in NSCLC and anticipates future evolution.

Play episode from 07:59
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app